trial

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

NCTId NCT07190352
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 15 (actual)
Sponsored by Vanderbilt University Medical Center
Primary completion 2022-10-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Na
Model
Crossover
Masking
None
Start
2021-10-04
Primary completion
2022-10-03
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
iTBS to the DMNcTBS to the DMN

Sponsors

Vanderbilt University Medical CenterLead Sponsor
Beth Israel Deaconess Medical CenterCollaborator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2022-10-03
Status
COMPLETED
relationships
The graph out of here
drug
iTBS to the DMN
drug
cTBS to the DMN
drug
lead_sponsor
Vanderbilt University Medical Center
company
collaborator
Beth Israel Deaconess Medical Center
company
indication
Nicotine Use
indication
Schizophrenia
indication
SCHIZOPHRENIA 1 (Disorder)
indication